Laboratorio Unico Metropolitano: innovazione e alta tecnologia per un nuovo paradigma di medicina di laboratorio

Journal title MECOSAN
Author/s Aldo Bonadies, Rita Mancini, Marilia Maci, Chiara Gibertoni, Anna Maria Petrini
Publishing Year 2021 Issue 2020/115
Language Italian Pages 16 P. 79-94 File size 199 KB
DOI 10.3280/MESA2020-115005
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

LUM: it’s an acronym for the new and unique laboratory of bologna metropolitan area. It is a health planning intervention born by regional indications and aimed at redefining production capacities through the reduction of duplication. The LUM is an example of network integration between structures and above all among health professionals. It is the first example in Italy of cession of the business branch among Public Companies: Teaching Hospital St. Orsola- Malpighi (AOU), Local Health Autority of Imola (AUSL Imola), Orthopedic Institute Rizzoli (IOR) have "sold" human and technological resources, as well as contracts of any nature relating to the activities of laboratory diagnostics of clinical pathology, at the Local Health Authority of Bologna (AUSL Bologna), identified as the project leading company, where the structure of the single laboratory is based.

Keywords: Clinical pathology, laboratory, cession of the business branch, Hub & Spoke organizations, innovation, integration.

  1. Cleveland Clinic website: -- http://my.clevelndclinic.org/aboutcleveland-clinic.
  2. Fulop N. et al. (2005). Changing organizations: a study of the context and processes of mergers of healt care providers in England. Soc Sci Med, 60: 119-130.
  3. Germany: Health reform triggers sharpdrop in unmber of hospital. Allianz website 2005. -- https://www.allianz.com/content/dam/onemarketing/azcom/Allianz_com/migration/media/current/en/media/images/pdf/saobj_1065254_saobj_935702_ewp_krankenh_user_06_20051.pdf.
  4. Hallworth M.J. (2011). The 70% claim: what is the evidence base?. Ann Clin Biochem., 48: 487-8.
  5. Hicks J.M. (1999). Consolidation of laboratories: does it work?. J Lab Autom, 4: 66-7.
  6. Kenneth A Sikaris (2017). Enhancing the Clinical Value of Medical Laboratory Testing. Clin Biochem Rev. 2017 Nov; 38(3): 107-114.
  7. Mayo Clinic website: -- http://mayoclinic.org/about-mayo-clinic.
  8. Report of second fase of the Review of NHS Pathology services in England 2010.
  9. Risebrow H. (2013). Modernising pathology commercial lessons from Europe. ACBNews, the association of clinical biochemistry and lab med., 604: 12-3.
  10. Rohr U.P., Binder C., Dieterle T., Giusti F., Messina C.G., Toerien E. et al. (2016). The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report. PLoS One, 11: e0149856.
  11. Satta G. et al. (2018). Consolidation of pathology services in England: have savings been achieved?. BMC Health Services research, 18: 862.
  12. Shmitt M. (2017). Do hospital mergers reduce costs?. K. Health Econ, (52): 74-94.
  13. Sikaris K.A. (2017). Enhancing the Clinical Value of Medical Laboratory Testing. Clin. Biochem. Rev., Nov., 38(3): 107-114.

  • Mathematical programming formulations and metaheuristics for biological sample transportation problems in healthcare Mario Benini, Paolo Detti, Garazi Zabalo Manrique de Lara, in Computers & Operations Research 105921/2022 pp.105921
    DOI: 10.1016/j.cor.2022.105921

Aldo Bonadies, Rita Mancini, Marilia Maci, Chiara Gibertoni, Anna Maria Petrini, Laboratorio Unico Metropolitano: innovazione e alta tecnologia per un nuovo paradigma di medicina di laboratorio in "MECOSAN" 115/2020, pp 79-94, DOI: 10.3280/MESA2020-115005